PharmaNet Development Group To Present at the UBS 20th Annual Global Healthcare Services Conference on February 9, 2010
PRINCETON, N.J., Feb. 2 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Jeffrey P. McMullen, president and chief executive officer, will make a presentation on the Company at the UBS 20th Annual Global Healthcare Services Conference in New York on Tuesday, February 9, 2010 at 2:00 pm EST.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and more than 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.
Contact: |
Anne-Marie Hess |
|
Phone: (609) 951-6842 |
||
Email: [email protected] |
||
SOURCE PharmaNet Development Group, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article